• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

格雷夫斯眼病中的自身免疫:促甲状腺激素受体和 IGF-1 受体之间不幸联姻的结果?

Autoimmunity in Graves' ophthalmopathy: the result of an unfortunate marriage between TSH receptors and IGF-1 receptors?

机构信息

Department of Endocrinology and Metabolism, Academic Medical Center, Amsterdam 1105 AZ, The Netherlands.

出版信息

J Clin Endocrinol Metab. 2011 Aug;96(8):2386-94. doi: 10.1210/jc.2011-0307. Epub 2011 Jun 15.

DOI:10.1210/jc.2011-0307
PMID:21677036
Abstract

CONTEXT

The immunopathogenesis of Graves' ophthalmopathy (GO) is still incompletely understood. Attention has shifted from the TSH receptor (TSHR) to the IGF-I receptor (IGF-1R) as a major autoantigen. This review on the pathophysiology of GO focused on orbital fibroblasts and the question whether autoimmunity against TSHR or IGF-1R is primarily involved.

EVIDENCE ACQUISITION

Relevant papers on GO were identified by a search on PubMed and scrutiny of their reference lists. In addition, abstracts presented on GO at the 14th International Thyroid Congress in 2010 in Paris, France, were read.

EVIDENCE SYNTHESIS

Orbital fibroblasts (OF) are recognized as the prime target cells of the autoimmune attack in GO. In early stages OF are undifferentiated with low TSHR expression and are stimulated to produce hyaluronan by cytokines (released by activated infiltrating T cells) and not by Graves' IgG. OF lacking the surface glycoprotein Thy-1 (not present in the muscle compartment) may differentiate into adipocytes, associated with increased TSHR expression. Graves IgG stimulate hyaluronan in differentiated OF mostly via non-cAMP signaling pathways for growth, which can also be activated via TSHR. The existence of IGF-1R stimulating antibodies in serum remains dubious. Autoimmunity against IGF-1R is also observed in rheumatoid arthritis and is not specific for Graves' disease. Expression of IGF-1R on T and B lymphocytes may contribute to autoimmunity against fibroblasts.

CONCLUSION

Autoimmunity against TSHR is most likely initiating the immune response in GO. Autoimmunity against IGF-1R is not specific for Graves' DISEASE but may contribute to ongoing immune reactions.

摘要

背景

格雷夫斯眼病(GO)的免疫发病机制仍不完全清楚。人们的注意力已经从促甲状腺激素受体(TSHR)转移到胰岛素样生长因子-I 受体(IGF-1R),认为它是主要的自身抗原。这篇关于 GO 病理生理学的综述重点关注眼眶成纤维细胞,并提出了一个问题,即针对 TSHR 或 IGF-1R 的自身免疫反应是否是主要的参与因素。

证据获取

通过在 PubMed 上搜索并仔细查阅其参考文献,确定了与 GO 相关的论文。此外,还阅读了在 2010 年法国巴黎举行的第 14 届国际甲状腺大会上关于 GO 的摘要。

证据综合

眼眶成纤维细胞(OF)被认为是 GO 中自身免疫攻击的主要靶细胞。在早期,OF 是未分化的,TSHR 表达水平较低,它们受到细胞因子(由激活的浸润 T 细胞释放)的刺激产生透明质酸,而不是 Graves 免疫球蛋白。缺乏表面糖蛋白 Thy-1(肌肉组织中不存在)的 OF 可能分化为脂肪细胞,同时 TSHR 表达增加。Graves 免疫球蛋白通过非 cAMP 信号通路刺激分化的 OF 产生透明质酸,主要用于生长,也可以通过 TSHR 激活。血清中存在 IGF-1R 刺激抗体的说法仍存在争议。针对 IGF-1R 的自身免疫也在类风湿关节炎中观察到,并且不是 Graves 病所特有的。T 和 B 淋巴细胞上 IGF-1R 的表达可能有助于针对成纤维细胞的自身免疫。

结论

针对 TSHR 的自身免疫反应很可能是 GO 中免疫反应的起始因素。针对 IGF-1R 的自身免疫反应不是 Graves 病所特有的,但可能有助于持续的免疫反应。

相似文献

1
Autoimmunity in Graves' ophthalmopathy: the result of an unfortunate marriage between TSH receptors and IGF-1 receptors?格雷夫斯眼病中的自身免疫:促甲状腺激素受体和 IGF-1 受体之间不幸联姻的结果?
J Clin Endocrinol Metab. 2011 Aug;96(8):2386-94. doi: 10.1210/jc.2011-0307. Epub 2011 Jun 15.
2
Effects of thyrotropin and thyrotropin-receptor-stimulating Graves' disease immunoglobulin G on cyclic adenosine monophosphate and hyaluronan production in nondifferentiated orbital fibroblasts of Graves' ophthalmopathy patients.促甲状腺素和促甲状腺素受体刺激 Graves 病免疫球蛋白 G 对 Graves 眼病患者未分化眼眶成纤维细胞中环腺苷酸单磷酸和透明质酸产生的影响。
Thyroid. 2010 May;20(5):535-44. doi: 10.1089/thy.2009.0447.
3
Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves' ophthalmopathy.眼眶成纤维细胞在格雷夫斯眼病发病机制中作用的当前观点
Exp Eye Res. 2016 Jan;142:83-91. doi: 10.1016/j.exer.2015.02.007.
4
TSH/IGF-1 Receptor Cross Talk in Graves' Ophthalmopathy Pathogenesis.格雷夫斯眼病发病机制中的促甲状腺激素/胰岛素样生长因子-1受体相互作用
J Clin Endocrinol Metab. 2016 Jun;101(6):2340-7. doi: 10.1210/jc.2016-1315. Epub 2016 Apr 4.
5
PDGF enhances orbital fibroblast responses to TSHR stimulating autoantibodies in Graves' ophthalmopathy patients.血小板衍生生长因子增强甲状腺刺激素受体刺激自身抗体在格雷夫斯眼病患者眼眶成纤维细胞的反应。
J Clin Endocrinol Metab. 2012 Jun;97(6):E944-53. doi: 10.1210/jc.2012-1020. Epub 2012 Mar 21.
6
Role of insulin-like growth factor-1 (IGF-1) pathway in the pathogenesis of Graves' orbitopathy.胰岛素样生长因子-1(IGF-1)通路在格雷夫斯眼病发病机制中的作用。
Best Pract Res Clin Endocrinol Metab. 2012 Jun;26(3):291-302. doi: 10.1016/j.beem.2011.10.002.
7
Evidence That Graves' Ophthalmopathy Immunoglobulins Do Not Directly Activate IGF-1 Receptors.没有证据表明格雷夫斯眼病免疫球蛋白直接激活 IGF-1 受体。
Thyroid. 2018 May;28(5):650-655. doi: 10.1089/thy.2018.0089. Epub 2018 Apr 30.
8
Mechanisms in Graves Eye Disease: Apoptosis as the End Point of Insulin-Like Growth Factor 1 Receptor Inhibition.格雷夫斯眼病的发病机制:胰岛素样生长因子 1 受体抑制的终点为细胞凋亡。
Thyroid. 2022 Apr;32(4):429-439. doi: 10.1089/thy.2021.0176.
9
Thyrotropin receptor-stimulating Graves' disease immunoglobulins induce hyaluronan synthesis by differentiated orbital fibroblasts from patients with Graves' ophthalmopathy not only via cyclic adenosine monophosphate signaling pathways.促甲状腺素受体刺激性 Graves 眼病免疫球蛋白不仅通过环腺苷酸信号通路诱导 Graves 眼病患者分化的眼眶成纤维细胞合成透明质酸。
Thyroid. 2011 Feb;21(2):169-76. doi: 10.1089/thy.2010.0123. Epub 2010 Oct 18.
10
Forkhead Transcription Factor FOXO1 Is Regulated by Both a Stimulatory Thyrotropin Receptor Antibody and Insulin-Like Growth Factor-1 in Orbital Fibroblasts from Patients with Graves' Ophthalmopathy.叉头转录因子FOXO1在格雷夫斯眼病患者眼眶成纤维细胞中受刺激性促甲状腺素受体抗体和胰岛素样生长因子-1的共同调控。
Thyroid. 2015 Oct;25(10):1145-50. doi: 10.1089/thy.2015.0254. Epub 2015 Aug 19.

引用本文的文献

1
Thyroid hormone signaling in ocular development and diseases.甲状腺激素信号在眼部发育和疾病中的作用
Biol Res. 2025 Jul 2;58(1):42. doi: 10.1186/s40659-025-00618-1.
2
Molecular pathway and mechanism responsible for the progress of thyroid-associated orbitopathy.甲状腺相关性眼病进展的分子途径及机制
Int Ophthalmol. 2025 May 17;45(1):197. doi: 10.1007/s10792-025-03564-9.
3
In vivo and in vitro evidence for a protective role of autoantibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves' orbitopathy.
自身抗体对格雷夫斯眼眶病中胰岛素样生长因子-1受体(IGF-1R)具有保护作用的体内和体外证据。
Endocrine. 2025 Mar 29. doi: 10.1007/s12020-025-04219-6.
4
Thyroid-associated ophthalmopathy: the role of oxidative stress.甲状腺相关眼病:氧化应激的作用。
Front Endocrinol (Lausanne). 2024 Jul 11;15:1400869. doi: 10.3389/fendo.2024.1400869. eCollection 2024.
5
Novel insights into the pathogenesis of thyroid eye disease through ferroptosis-related gene signature and immune infiltration analysis.通过铁死亡相关基因特征和免疫浸润分析对甲状腺眼病发病机制的新见解
Aging (Albany NY). 2024 Mar 25;16(7):6008-6034. doi: 10.18632/aging.205685.
6
Dysthyroid optic neuropathy: emerging treatment strategies.甲状腺相关眼病:新兴治疗策略。
J Endocrinol Invest. 2023 Jul;46(7):1305-1316. doi: 10.1007/s40618-023-02036-0. Epub 2023 Feb 18.
7
A review of TSHR- and IGF-1R-related pathogenesis and treatment of Graves' orbitopathy.促甲状腺激素受体和胰岛素样生长因子 1 受体相关发病机制与 Graves 眼病治疗的研究进展。
Front Immunol. 2023 Jan 19;14:1062045. doi: 10.3389/fimmu.2023.1062045. eCollection 2023.
8
Inflammasome activation as a link between obesity and thyroid disorders: Implications for an integrated clinical management.作为肥胖症与甲状腺疾病之间关联的纽带,炎症小体的激活:对综合临床管理的启示。
Front Endocrinol (Lausanne). 2022 Aug 19;13:959276. doi: 10.3389/fendo.2022.959276. eCollection 2022.
9
Current concepts regarding Graves' orbitopathy.当前关于格雷夫斯眼病的概念。
J Intern Med. 2022 Nov;292(5):692-716. doi: 10.1111/joim.13524. Epub 2022 Jun 1.
10
Dysthyroid Optic Neuropathy: Treatment with Additional Intravenous Methylprednisolone Pulses after the Basic Schedule Is Associated with Stabilization or Further Improvement of Clinical Outcome.甲状腺功能异常性视神经病变:基础治疗方案后追加静脉注射甲泼尼龙冲击治疗与临床结局稳定或进一步改善相关。
J Clin Med. 2022 Apr 7;11(8):2068. doi: 10.3390/jcm11082068.